Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen.
Year: 2002
Type: article
Source: PubMed
Institution: University of Manchester
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2164996011
